AHR suppresses the viability and migration of human prostate cancer LNCaP cells (Yu et al., 2017), and plays pivotal role in cancer by modulating the downstream expression of Mitogen-Activated Protein Kinase Kinase Kinase 12 (MAP3K12) (Yu et al., 2018). This evidence concerns the gene MAP3K12 and prostate cancer.